A Stanford-led team developed a machine-learning model that predicts donor death timing, reducing canceled liver transplants and improving resource use.
Key Details
- 1A machine-learning model predicts whether donors will die within 30–45 minutes after life support removal, enabling timely liver transplantation.
- 2The model was trained on over 2,000 cases from six US transplant centers and outperformed surgeons’ judgment (75% vs 65% accuracy).
- 3Futile procurement rates (resources spent without a successful transplant) dropped by 60% using the model.
- 4Missed transplant opportunities remained similar to surgeon judgment (just over 15%), but further model refinements lowered this to ~10% in recent tests.
- 5The model incorporates donor demographics, vitals, lab results, ventilator settings, and neurological assessments, and features a natural language interface for clinical data extraction.
- 6It is customizable to clinical and hospital preferences and is being adapted for heart and lung transplantation.
Why It Matters
This research demonstrates the growing potential of machine learning in high-stakes surgical decision-making, supporting better allocation of scarce organs and healthcare resources. Increased accuracy and efficiency can enhance patient outcomes, reduce waste, and potentially expand AI's role into more imaging-driven and perioperative workflows.
Source
EurekAlert
Related News
•EurekAlert
UVA's $4M NIH Grant Backs AI to Optimize Cardiac MRI Therapies
UVA secures $4 million NIH funding to develop GenStrain, an AI model using MRI data to personalize cardiac pacing therapies.
•EurekAlert
Machine Learning Models Predict Cancer Risk with Routine Health Data
Researchers developed machine learning models using routinely collected health data to predict individual risk for 20 common cancers, outperforming traditional methods for several cancer types.
•EurekAlert
Duke Receives $25M to Lead National Trustworthy AI Hub for Dementia and Aging
Duke University has launched a $25 million national center to make AI for aging and dementia clinically robust and trustworthy.